In in silico analyses of TCGA colon cancer cohort, data also confirmed that patients with low IL-18 expression had a lower 10-year survival rate than patients with high IL-18 expression (P = 0.00028, Figure 3(c)). The gene discussed is IL18; the disease is colonic neoplasm.